Validation of use of the Nageotte hemocytometer to count low levels of white cells in white cell-reduced platelet components.
about
Intrauterine use of hyperconcentrated platelet concentrates collected with Trima Accel in a case of neonatal alloimmune thrombocytopenia.Storage of buffy-coat-derived platelets in additive solution: in vitro effects on platelets of the air bubbles and foam included in the final unitPathogen inactivation of double-dose buffy-coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro function.The effects of pneumatic tube transport on fresh and stored platelets in additive solution.Storage of platelets: effects associated with high platelet content in platelet storage containers.In vitro assessment of platelet storage lesion in leucoreduced random donor platelet concentrates.Leucodepletion and Blood Products.von Willebrand factor, clotting factors, and clotting inhibitors in apheresis platelet concentrates.Evaluation of performance of white blood cell reduction filters: an original flow cytometric method for detection and quantification of cell-derived membrane fragments.First comparison of productivity and citrate donor load between the Trima version 4 (dual-stage filler) and the Trima Accel (single-stage filler) in the same donors.Random aggregates in newly produced platelet units are associated with platelet activation and release of the immunomodulatory factors sCD40L and RANTES.Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study.In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution.Portable microscopic cell counter for the determination of residual leucocytes in blood components.Storage of interim platelet units for 18 to 24 hours before pooling: in vitro study.Evaluation of a new apheresis system for the collection of leukoreduced single-donor platelets.Collection of hyperconcentrated platelets with Trima Accel.Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro quality.Methods for counting residual leukocytes in leukocyte-depleted plasma-a comparison between a routine hematology instrument, the Nageotte chamber, flow cytometry, and a fluorescent microscopy analyzer.In vitro affinity reduction of biologic response modifiers from production buffy coat platelets exposed to recombinant protein receptors.Storage of buffy coat-derived platelets in additive solutions: in vitro effects of storage at 4 degrees C.
P2860
Q33376001-21B9D474-0182-4E74-B003-83E3368132A4Q34988657-916C4A91-4CB9-467F-BF1D-B5AB220A6780Q41627658-64B70EBB-875F-4D9C-AF1B-E5FB73E1C3B2Q41960403-A270FF04-0D4E-4ED0-A86D-094231F7CF8AQ41963369-44F0F293-2C13-4F3A-9830-DC03EE8CCC7EQ42116021-F9637825-0224-433D-BC4C-162BF09CD786Q42533942-28758F61-3709-4802-ACAE-3F9A85682E46Q43421575-1C0FFE0A-EF71-4B39-8C10-829D27E31438Q44458610-B49A8FAF-4D2F-4527-9800-4F89384CFD0FQ44665823-5B6221A6-5974-45DA-8A95-7D7528777F85Q46653073-558F2649-2432-4921-8220-802941DDCC79Q46808800-1FE74488-80D0-4CA7-8E73-79D6D38A4A1BQ46885219-A6E70B8F-3121-4079-837D-9096CEBB46BEQ48332357-D49091C0-436E-4C1D-B122-A7B6CD403FB2Q50551381-C742AA13-6457-4F1F-A694-B106F74CA07BQ50996162-1F929680-6EEF-4F32-9CE4-CA2D63E55F9EQ51283612-9874E5AC-BCB0-4E9B-94F0-B12BD514550DQ51442710-686C8553-56B2-4114-9AB2-699505094C02Q52918661-5AFE41FA-20A3-4036-A877-BD2623E3AEC7Q53590035-00D91F57-429C-464F-BD10-7D6CCF29090EQ53623542-E09C5CDD-F8EA-4CBC-903F-15E86AC6F6E5
P2860
Validation of use of the Nageotte hemocytometer to count low levels of white cells in white cell-reduced platelet components.
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Validation of use of the Nageo ...... l-reduced platelet components.
@ast
Validation of use of the Nageo ...... l-reduced platelet components.
@en
Validation of use of the Nageo ...... l-reduced platelet components.
@nl
type
label
Validation of use of the Nageo ...... l-reduced platelet components.
@ast
Validation of use of the Nageo ...... l-reduced platelet components.
@en
Validation of use of the Nageo ...... l-reduced platelet components.
@nl
prefLabel
Validation of use of the Nageo ...... l-reduced platelet components.
@ast
Validation of use of the Nageo ...... l-reduced platelet components.
@en
Validation of use of the Nageo ...... l-reduced platelet components.
@nl
P2093
P1433
P1476
Validation of use of the Nageo ...... l-reduced platelet components.
@en
P2093
P356
10.1046/J.1537-2995.1994.34194098600.X
P577
1994-01-01T00:00:00Z